Ledger.Open graph →
SEC Form D · filed June 7, 2021

NiKang Therapeutics, Inc

Offering
$200.0M
Sold
$200.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Wilmington, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Roderick Wong · NEW YORK, NYDirectorWei Fu · Grand Cayman, Cayman IslandsDirectorZhengbin Yao · Wilmington, DEDirectorGary Yeung · Wilmington, DEDirectorTing Jia · Wilmington, DEDirectorHong (Kelsey) Chen · Wilmington, DEExecZhenhai Gao · Wilmington, DEExec · DirectorSean Cao · Wilmington, DEDirectorGary Yeung · Wilmington, DEDirectorTing Jia · Wilmington, DEDirectorHong (Kelsey) Chen · Wilmington, DEExecZhenhai Gao · Wilmington, DEExec · DirectorRoderick Wong · NEW YORK, NYDirectorWei Fu · Grand Cayman, Cayman IslandsDirectorZhengbin Yao · Wilmington, DEDirectorSean Cao · Wilmington, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗